Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
07/10/2012 | CA2462564C Methods of inhibiting metastases |
07/10/2012 | CA2446356C Use of compositions for treating rosacea |
07/10/2012 | CA2444821C Combination therapy using anti-angiogenic agents and tnfa |
07/10/2012 | CA2444704C Synthesis and evaluation of phthalimide mimics as anti-angiogenic agents |
07/10/2012 | CA2440010C Powder inhaler formulations |
07/10/2012 | CA2435712C Universal carrier for targeting molecules to gb3 receptor expressing cells |
07/10/2012 | CA2417960C Method of using diketopiperazines and composition containing them |
07/10/2012 | CA2368677C Intramyocardial injection of autologous bone marrow |
07/10/2012 | CA2360003C Tricyclic inhibitors of poly(adp-ribose) polymerases |
07/10/2012 | CA2340790C Human il-1 epsilon dna and polypeptides |
07/10/2012 | CA2211324C Recombinant human alpha-fetoprotein and uses thereof |
07/10/2012 | CA2210992C Mixture of fatty acids, derivatives and a compound of vegetal origin having attractive effect on cats |
07/05/2012 | WO2012091571A2 Combination of components for the prevention and treatment of frailty |
07/05/2012 | WO2012091115A1 Acetylene derivative and pharmaceutical application therefor |
07/05/2012 | WO2012091081A1 Interferon production-inducing agent containing lactic acid bacteria |
07/05/2012 | WO2012091010A1 Bicyclic pyrimidine derivative |
07/05/2012 | WO2012090713A1 Concomitant drug for improving cognitive function |
07/05/2012 | WO2012090676A1 Novel medicinal composition and utilization of same |
07/05/2012 | US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta |
07/05/2012 | US20120172378 Novel compounds |
07/05/2012 | US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
07/05/2012 | US20120172333 Pyrrolo-pyridine derivatives as activators of ampk |
07/05/2012 | US20120171309 Formulations and methods for increasing efficacies and improving flavors of formulations containing gynostemma plant |
07/05/2012 | US20120171284 Celecoxib compositions |
07/05/2012 | US20120171184 Cellular hydration compositions |
07/05/2012 | US20120171151 Mass spectrometric quantitation assay for metabolites of leflunomide |
07/05/2012 | CA2823306A1 Combination of components for the prevention and treatment of frailty |
07/04/2012 | EP2471918A1 Screening method |
07/04/2012 | EP2471916A1 Diagnosis marker, diagnosis method and therapeutic agent for amyotrophic lateral sclerosis, and animal model and cell model developing amyotrophic lateral sclerosis |
07/04/2012 | EP2471793A1 Fused heterocyclic ring derivative and use thereof |
07/04/2012 | EP2471791A1 Fused heterocyclic ring derivative and use thereof |
07/04/2012 | EP2471790A1 Fused heterocyclic ring derivative and use thereof |
07/04/2012 | EP2471789A1 Fused heterocyclic ring derivative and use thereof |
07/04/2012 | EP2471786A1 Aminopyrazole derivative |
07/04/2012 | EP2471782A1 Novel sulfonamide derivative and pharmaceutical product containing same |
07/04/2012 | EP2471777A1 Novel tetrahydroisoquinoline compounds |
07/04/2012 | EP2471547A1 Apoptosis inducer |
07/04/2012 | EP2471533A1 Aryl carbonyl derivatives as therapeutic agents |
07/04/2012 | EP2257555B1 Thieno[2,3-d]-pyrimidine-4(3h)-one compounds with antifungal properties and process thereof |
07/04/2012 | EP2062887B1 Aminopyridine derivative having aurora a-selective inhibitory activity |
07/04/2012 | EP1817036B1 Modulators of muscarinic receptors |
07/04/2012 | EP1550662B1 Adenine compound and use thereof |
07/04/2012 | EP1487805B1 Pyrimidine derivatives |
07/04/2012 | EP1485094B1 Dosage form for oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester or its salts |
07/04/2012 | EP1439858B1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
07/04/2012 | CN1962641B Metalloproteinase inhibitors |
07/04/2012 | CN1907967B Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
07/04/2012 | CN1845911B Condensed ring compound and use thereof |
07/04/2012 | CN1449386B Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
07/04/2012 | CN1338939B Compositions for the treatment of male erectile dysfunction |
07/04/2012 | CN102549153A Prophylactic and/or therapeutic agent for metabolic syndrome |
07/04/2012 | CN102548985A Substituted carbonyl compounds |
07/04/2012 | CN102548965A 取代酰胺化合物 Substituted amide compounds |
07/04/2012 | CN102548945A Apogossypolone derivatives as anticancer agents |
07/04/2012 | CN102533640A A method to producing a spheroid population of adult stem cells |
07/04/2012 | CN102532264A Peptide-based compounds |
07/04/2012 | CN102532159A Small molecule inhibitors Syntelin for centromere-associated protein E (CENP-E) |
07/04/2012 | CN102532051A 有丝分裂驱动蛋白抑制剂及其使用方法 Mitotic kinesin inhibitors and methods of use |
07/04/2012 | CN102531995A 3,3'-disubstituted-3-hydroxy bis-indolinone derivative and preparation method and application thereof |
07/04/2012 | CN102531948A 氨基-甲基取代的四环素类化合物 Amino - methyl-substituted tetracycline compounds |
07/04/2012 | CN102526629A Traditional Chinese medicine for treating forehead perspiration symptom |
07/04/2012 | CN102526575A Preparation technology and production method of novel five-flavor decoction integrated dosage form |
07/04/2012 | CN102526496A Traditional Chinese medicine composition for treating fire excess from yin deficiency type sleepless night sweating symptoms, and preparation method of traditional Chinese medicine composition |
07/04/2012 | CN102526352A Medicine for treating pediatric hernia and preparing method thereof |
07/04/2012 | CN102526329A Traditional Chinese medicine for treating night sweat symptom |
07/04/2012 | CN102526215A Extraction technology for removing polygala tenuifolia toxic substances and keeping anti-depressant effective components |
07/04/2012 | CN102526182A Application of Prunella vulgaris Linn. and extract of Prunella vulgaris Linn. to preparation of product for inhibiting angiogenesis |
07/04/2012 | CN102526129A Method for preparing Poria cocos granules by replacing part of auxiliary materials with ultrafine powder |
07/04/2012 | CN102526108A Method for commercial production of bezoar |
07/04/2012 | CN102526094A Medicine for treating swine high fever disease |
07/04/2012 | CN102526045A Methods of increasing endogenous erythropoietin EPO |
07/04/2012 | CN102526044A Methods of increasing endogenous erythropoietin EPO |
07/04/2012 | CN102525910A Process for preparing penehyclidine hydrochloride injection |
07/04/2012 | CN102525909A Method for preparing penehyclidine hydrochloride injection |
07/04/2012 | CN102205071B Chinese medicinal composition for treating thyroid cyst |
07/04/2012 | CN102153650B Anti-EGFR (epidemic growth factor receptor) humanized antibody L2-H3 and coding gene and application thereof |
07/04/2012 | CN102153649B Anti-epidemic growth factor receptor (EGFR) humanized antibody L1-H3 and coded gene and application thereof |
07/04/2012 | CN102153648B EGFR (epidermal growth factor receptor)-inhibiting humanized antibody L4-H3 and encoding genes and application thereof |
07/04/2012 | CN102153647B Anti-EGFR (epidemic growth factor receptor) humanized antibody L3-H3 and coding gene and application thereof |
07/04/2012 | CN102091304B Chinese medicine oral liquid with functions of restoring yang qi and dispelling cold and preparation method thereof |
07/04/2012 | CN101898982B Npy y5 antagonists |
07/04/2012 | CN101892189B Transformant for blocking effect of porcine somatostatin by oral immunization and application thereof |
07/04/2012 | CN101816721B Chinese medicinal composition for treating children fever caused by exogenous pathogens and preparation method thereof |
07/04/2012 | CN101654453B Process for the manufacture of the calcium salt of rosuvatatin and crystalline intermediates thereof |
07/04/2012 | CN101574392B Prevention and treatment of diseases induced by microcirculation disturbance with total salvianolic acid |
07/04/2012 | CN101524378B Anti-ageing traditional Chinese medicine preparation |
07/04/2012 | CN101491536B Therapeutically useful synthetic oligonucleotides |
07/04/2012 | CN101401874B Lozenge for refreshing oneself and preparation method thereof |
07/04/2012 | CN101296693B 持久力提高剂 Endurance enhancing agent |
07/04/2012 | CN101259120B Methods of inducing terminal differentiation |
07/04/2012 | CN101209344B Application of hyperosmotic fluid composition in preparing medicament for improving wound healing |
07/04/2012 | CN101115763B Novel polyphenol glycoside derived from acerola |
07/04/2012 | CN101106987B Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
07/04/2012 | CN101092455B Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
07/03/2012 | US8212057 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
07/03/2012 | US8211945 Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient |
07/03/2012 | US8211666 Sperm-specific cation channel, CATSPER1, and uses therefor |
07/03/2012 | US8211421 Mutant having uracil phosphoribosyl transferase activity |
07/03/2012 | CA2640956C B7rp-1 polypeptides |
07/03/2012 | CA2463814C Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |